nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Lacrimation—Fluorouracil—head and neck cancer	0.0289	0.029	CcSEcCtD
Doxylamine—Lacrimation—Docetaxel—head and neck cancer	0.0208	0.0209	CcSEcCtD
Doxylamine—Lacrimation increased—Fluorouracil—head and neck cancer	0.0184	0.0185	CcSEcCtD
Doxylamine—Redness—Docetaxel—head and neck cancer	0.0182	0.0182	CcSEcCtD
Doxylamine—Liver disorder—Docetaxel—head and neck cancer	0.018	0.018	CcSEcCtD
Doxylamine—Breast disorder—Hydroxyurea—head and neck cancer	0.0155	0.0155	CcSEcCtD
Doxylamine—Pancytopenia—Vinblastine—head and neck cancer	0.0154	0.0155	CcSEcCtD
Doxylamine—Rhinorrhoea—Docetaxel—head and neck cancer	0.0151	0.0152	CcSEcCtD
Doxylamine—Pancreatitis—Hydroxyurea—head and neck cancer	0.0145	0.0146	CcSEcCtD
Doxylamine—Depression—Vinblastine—head and neck cancer	0.0144	0.0145	CcSEcCtD
Doxylamine—Pancytopenia—Hydroxyurea—head and neck cancer	0.0141	0.0141	CcSEcCtD
Doxylamine—Bone disorder—Docetaxel—head and neck cancer	0.0136	0.0136	CcSEcCtD
Doxylamine—Agranulocytosis—Vinblastine—head and neck cancer	0.0135	0.0136	CcSEcCtD
Doxylamine—Lacrimation increased—Docetaxel—head and neck cancer	0.0133	0.0133	CcSEcCtD
Doxylamine—Drowsiness—Hydroxyurea—head and neck cancer	0.0132	0.0132	CcSEcCtD
Doxylamine—Hallucination—Hydroxyurea—head and neck cancer	0.0118	0.0118	CcSEcCtD
Doxylamine—Irritability—Fluorouracil—head and neck cancer	0.0118	0.0118	CcSEcCtD
Doxylamine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.011	0.0111	CcSEcCtD
Doxylamine—Ill-defined disorder—Vinblastine—head and neck cancer	0.0105	0.0105	CcSEcCtD
Doxylamine—Erythema—Hydroxyurea—head and neck cancer	0.0103	0.0103	CcSEcCtD
Doxylamine—Malaise—Vinblastine—head and neck cancer	0.0102	0.0102	CcSEcCtD
Doxylamine—Vertigo—Vinblastine—head and neck cancer	0.0102	0.0102	CcSEcCtD
Doxylamine—Leukopenia—Vinblastine—head and neck cancer	0.0101	0.0102	CcSEcCtD
Doxylamine—Pancytopenia—Fluorouracil—head and neck cancer	0.0101	0.0102	CcSEcCtD
Doxylamine—Convulsion—Vinblastine—head and neck cancer	0.0098	0.00983	CcSEcCtD
Doxylamine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00957	0.0096	CcSEcCtD
Doxylamine—Discomfort—Vinblastine—head and neck cancer	0.00951	0.00955	CcSEcCtD
Doxylamine—Malaise—Hydroxyurea—head and neck cancer	0.0093	0.00933	CcSEcCtD
Doxylamine—Leukopenia—Hydroxyurea—head and neck cancer	0.00923	0.00926	CcSEcCtD
Doxylamine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00904	0.00907	CcSEcCtD
Doxylamine—Convulsion—Hydroxyurea—head and neck cancer	0.00894	0.00897	CcSEcCtD
Doxylamine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00886	0.0089	CcSEcCtD
Doxylamine—Anorexia—Vinblastine—head and neck cancer	0.0088	0.00883	CcSEcCtD
Doxylamine—Discomfort—Hydroxyurea—head and neck cancer	0.00868	0.00871	CcSEcCtD
Doxylamine—Dehydration—Docetaxel—head and neck cancer	0.00827	0.0083	CcSEcCtD
Doxylamine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00825	0.00828	CcSEcCtD
Doxylamine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00824	0.00827	CcSEcCtD
Doxylamine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00813	0.00815	CcSEcCtD
Doxylamine—Breast disorder—Docetaxel—head and neck cancer	0.00804	0.00807	CcSEcCtD
Doxylamine—Anorexia—Hydroxyurea—head and neck cancer	0.00802	0.00805	CcSEcCtD
Doxylamine—Decreased appetite—Vinblastine—head and neck cancer	0.00802	0.00805	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00801	0.00804	CcSEcCtD
Doxylamine—Cramp muscle—Docetaxel—head and neck cancer	0.00801	0.00804	CcSEcCtD
Doxylamine—Nasopharyngitis—Docetaxel—head and neck cancer	0.00796	0.00798	CcSEcCtD
Doxylamine—Constipation—Vinblastine—head and neck cancer	0.00789	0.00792	CcSEcCtD
Doxylamine—Feeling abnormal—Vinblastine—head and neck cancer	0.00761	0.00763	CcSEcCtD
Doxylamine—Bronchospasm—Docetaxel—head and neck cancer	0.00756	0.00759	CcSEcCtD
Doxylamine—Dyspnoea—Hydroxyurea—head and neck cancer	0.0075	0.00753	CcSEcCtD
Doxylamine—Somnolence—Hydroxyurea—head and neck cancer	0.00748	0.00751	CcSEcCtD
Doxylamine—Erythema—Fluorouracil—head and neck cancer	0.00742	0.00745	CcSEcCtD
Doxylamine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00732	0.00734	CcSEcCtD
Doxylamine—Pancytopenia—Docetaxel—head and neck cancer	0.0073	0.00733	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00727	0.00729	CcSEcCtD
Doxylamine—Fatigue—Hydroxyurea—head and neck cancer	0.00726	0.00728	CcSEcCtD
Doxylamine—Constipation—Hydroxyurea—head and neck cancer	0.0072	0.00722	CcSEcCtD
Doxylamine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00694	0.00696	CcSEcCtD
Doxylamine—Hypersensitivity—Vinblastine—head and neck cancer	0.0068	0.00682	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.0068	0.00682	CcSEcCtD
Doxylamine—Leukopenia—Fluorouracil—head and neck cancer	0.00664	0.00667	CcSEcCtD
Doxylamine—Asthenia—Vinblastine—head and neck cancer	0.00662	0.00665	CcSEcCtD
Doxylamine—Convulsion—Fluorouracil—head and neck cancer	0.00643	0.00645	CcSEcCtD
Doxylamine—Agranulocytosis—Docetaxel—head and neck cancer	0.0064	0.00642	CcSEcCtD
Doxylamine—Diarrhoea—Vinblastine—head and neck cancer	0.00631	0.00634	CcSEcCtD
Doxylamine—Discomfort—Fluorouracil—head and neck cancer	0.00624	0.00627	CcSEcCtD
Doxylamine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.0062	0.00622	CcSEcCtD
Doxylamine—Hepatitis—Docetaxel—head and neck cancer	0.00615	0.00618	CcSEcCtD
Doxylamine—Confusional state—Fluorouracil—head and neck cancer	0.00611	0.00613	CcSEcCtD
Doxylamine—Dizziness—Vinblastine—head and neck cancer	0.0061	0.00612	CcSEcCtD
Doxylamine—Urinary tract disorder—Docetaxel—head and neck cancer	0.00608	0.0061	CcSEcCtD
Doxylamine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00606	0.00608	CcSEcCtD
Doxylamine—Asthenia—Hydroxyurea—head and neck cancer	0.00604	0.00606	CcSEcCtD
Doxylamine—Urethral disorder—Docetaxel—head and neck cancer	0.00603	0.00605	CcSEcCtD
Doxylamine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00594	0.00596	CcSEcCtD
Doxylamine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00593	0.00595	CcSEcCtD
Doxylamine—Tachycardia—Fluorouracil—head and neck cancer	0.00591	0.00593	CcSEcCtD
Doxylamine—Vomiting—Vinblastine—head and neck cancer	0.00587	0.00589	CcSEcCtD
Doxylamine—Erythema multiforme—Docetaxel—head and neck cancer	0.00582	0.00584	CcSEcCtD
Doxylamine—Anorexia—Fluorouracil—head and neck cancer	0.00578	0.0058	CcSEcCtD
Doxylamine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00576	0.00578	CcSEcCtD
Doxylamine—Eye disorder—Docetaxel—head and neck cancer	0.00575	0.00577	CcSEcCtD
Doxylamine—Cardiac disorder—Docetaxel—head and neck cancer	0.00571	0.00573	CcSEcCtD
Doxylamine—Flushing—Docetaxel—head and neck cancer	0.00571	0.00573	CcSEcCtD
Doxylamine—Hypotension—Fluorouracil—head and neck cancer	0.00566	0.00568	CcSEcCtD
Doxylamine—Dizziness—Hydroxyurea—head and neck cancer	0.00557	0.00559	CcSEcCtD
Doxylamine—Immune system disorder—Docetaxel—head and neck cancer	0.00556	0.00558	CcSEcCtD
Doxylamine—Mediastinal disorder—Docetaxel—head and neck cancer	0.00555	0.00557	CcSEcCtD
Doxylamine—Nausea—Vinblastine—head and neck cancer	0.00548	0.0055	CcSEcCtD
Doxylamine—Insomnia—Fluorouracil—head and neck cancer	0.00548	0.0055	CcSEcCtD
Doxylamine—Dyspnoea—Fluorouracil—head and neck cancer	0.0054	0.00542	CcSEcCtD
Doxylamine—Somnolence—Fluorouracil—head and neck cancer	0.00539	0.0054	CcSEcCtD
Doxylamine—Erythema—Docetaxel—head and neck cancer	0.00536	0.00538	CcSEcCtD
Doxylamine—Vomiting—Hydroxyurea—head and neck cancer	0.00535	0.00537	CcSEcCtD
Doxylamine—Rash—Hydroxyurea—head and neck cancer	0.00531	0.00533	CcSEcCtD
Doxylamine—Dermatitis—Hydroxyurea—head and neck cancer	0.0053	0.00532	CcSEcCtD
Doxylamine—Decreased appetite—Fluorouracil—head and neck cancer	0.00527	0.00529	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00523	0.00525	CcSEcCtD
Doxylamine—Muscle spasms—Docetaxel—head and neck cancer	0.00515	0.00517	CcSEcCtD
Doxylamine—Nausea—Hydroxyurea—head and neck cancer	0.005	0.00502	CcSEcCtD
Doxylamine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00499	0.00501	CcSEcCtD
Doxylamine—Urticaria—Fluorouracil—head and neck cancer	0.00481	0.00483	CcSEcCtD
Doxylamine—Leukopenia—Docetaxel—head and neck cancer	0.0048	0.00481	CcSEcCtD
Doxylamine—Palpitations—Docetaxel—head and neck cancer	0.00473	0.00475	CcSEcCtD
Doxylamine—Convulsion—Docetaxel—head and neck cancer	0.00464	0.00466	CcSEcCtD
Doxylamine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00446	0.00448	CcSEcCtD
Doxylamine—Dry mouth—Docetaxel—head and neck cancer	0.00446	0.00448	CcSEcCtD
Doxylamine—Confusional state—Docetaxel—head and neck cancer	0.00441	0.00442	CcSEcCtD
Doxylamine—Anaphylactic shock—Docetaxel—head and neck cancer	0.00437	0.00439	CcSEcCtD
Doxylamine—Nervous system disorder—Docetaxel—head and neck cancer	0.00429	0.0043	CcSEcCtD
Doxylamine—Pruritus—Fluorouracil—head and neck cancer	0.00429	0.0043	CcSEcCtD
Doxylamine—Thrombocytopenia—Docetaxel—head and neck cancer	0.00428	0.0043	CcSEcCtD
Doxylamine—Tachycardia—Docetaxel—head and neck cancer	0.00427	0.00428	CcSEcCtD
Doxylamine—Anorexia—Docetaxel—head and neck cancer	0.00417	0.00418	CcSEcCtD
Doxylamine—Diarrhoea—Fluorouracil—head and neck cancer	0.00415	0.00416	CcSEcCtD
Doxylamine—Hypotension—Docetaxel—head and neck cancer	0.00409	0.0041	CcSEcCtD
Doxylamine—Dizziness—Fluorouracil—head and neck cancer	0.00401	0.00402	CcSEcCtD
Doxylamine—Insomnia—Docetaxel—head and neck cancer	0.00396	0.00397	CcSEcCtD
Doxylamine—Dyspnoea—Docetaxel—head and neck cancer	0.0039	0.00391	CcSEcCtD
Doxylamine—Somnolence—Docetaxel—head and neck cancer	0.00389	0.0039	CcSEcCtD
Doxylamine—Vomiting—Fluorouracil—head and neck cancer	0.00385	0.00387	CcSEcCtD
Doxylamine—Rash—Fluorouracil—head and neck cancer	0.00382	0.00383	CcSEcCtD
Doxylamine—Dermatitis—Fluorouracil—head and neck cancer	0.00382	0.00383	CcSEcCtD
Doxylamine—Decreased appetite—Docetaxel—head and neck cancer	0.0038	0.00381	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00378	0.00379	CcSEcCtD
Doxylamine—Fatigue—Docetaxel—head and neck cancer	0.00377	0.00378	CcSEcCtD
Doxylamine—Constipation—Docetaxel—head and neck cancer	0.00374	0.00375	CcSEcCtD
Doxylamine—Feeling abnormal—Docetaxel—head and neck cancer	0.0036	0.00362	CcSEcCtD
Doxylamine—Nausea—Fluorouracil—head and neck cancer	0.0036	0.00361	CcSEcCtD
Doxylamine—Hypersensitivity—Docetaxel—head and neck cancer	0.00322	0.00323	CcSEcCtD
Doxylamine—Asthenia—Docetaxel—head and neck cancer	0.00314	0.00315	CcSEcCtD
Doxylamine—Pruritus—Docetaxel—head and neck cancer	0.00309	0.0031	CcSEcCtD
Doxylamine—Diarrhoea—Docetaxel—head and neck cancer	0.00299	0.003	CcSEcCtD
Doxylamine—Dizziness—Docetaxel—head and neck cancer	0.00289	0.0029	CcSEcCtD
Doxylamine—Vomiting—Docetaxel—head and neck cancer	0.00278	0.00279	CcSEcCtD
Doxylamine—Rash—Docetaxel—head and neck cancer	0.00276	0.00277	CcSEcCtD
Doxylamine—Dermatitis—Docetaxel—head and neck cancer	0.00275	0.00276	CcSEcCtD
Doxylamine—Nausea—Docetaxel—head and neck cancer	0.0026	0.00261	CcSEcCtD
Doxylamine—Toremifene—CYP1A1—head and neck cancer	0.00249	0.715	CrCbGaD
Doxylamine—Tamoxifen—CYP1A1—head and neck cancer	0.000995	0.285	CrCbGaD
